Clinical trial
Comparison of the Cosmetic Outcome of Hypofractionated Versus Normofractionated Intensity Modulated Radiotherapy (IMRT) in Treatment of Breast Cancer: The KOSIMA Trial
NCT01403779 is registered in ClinicalTrials.gov with Universitätsmedizin Mannheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Cosmetic Outcome of Hypofractionated Versus Normofractionated Intensity Modulated Radiotherapy (IMRT) in Treatment of Breast Cancer: The KOSIMA Trial
- Lead sponsor
- Universitätsmedizin Mannheim
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2010
- Completion date
- February 2, 2017
- Enrollment
- 226 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, tumors